NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
Back to search
Official data from USPTO
IMMUNOONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOONE
ST13
US500000079361819Class
5, 42, 44
Filing
79361819
Registration
7204166
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
11/23/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
12/20/2022
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
AT
Examiner
CANTONE,KERI H
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OncoOne Research & Development GmbH
Representatives
Michael Fedrick Loza & Loza, LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalmedical and veterinary preparations for the treatment of hyperproliferative and inflammatory diseases; pharmaceuticalmedical and veterinary preparations comprising antibodiesantibody derivativesantigen binding fragments for the treatment of hyperproliferative and inflammatory diseases
Class 42
Scientific and technological services and researchscientific researchanalysis and testing in the field of diseases using antibodiesantibody derivatives and antigen binding fragments; scientific and technological services and research in the nature of scientific research for the treatment and prevention of diseases using antibodiesantibody derivativesantigen binding fragments; analytical and research services; analytical scientific research and medical and scientific research servicesdescriptivediagnosticpredictive and prescriptive analytics for the treatment and prevention of disease using antibodiesantibody derivativesantigen binding fragments; pharmaceutical and biotechnological research and development; biotechnological research services
Class 44
Medical and veterinary servicesservices for the treatment and prevention of diseases using antibodiesantibody derivativesantigen binding fragments
Publications
History of USPTO decisions and trademark events.
28 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/27/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2024
FIMP
FINAL DISPOSITION PROCESSED
02/06/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/31/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2023
RFNT
REFUSAL PROCESSED BY IB
05/31/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/05/2023
RFRR
REFUSAL PROCESSED BY MPU
05/05/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/17/2023
CNRT
NON-FINAL ACTION WRITTEN
03/16/2023
DOCK
ASSIGNED TO EXAMINER
03/14/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2023
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.